Neralie Ann Coulston

Title: Neralie Ann Coulston: Innovator in Nucleic Acid Treatment

Introduction

Neralie Ann Coulston is a notable inventor based in Avalon Beach, Australia. She has made significant contributions to the field of genetic research, particularly in the treatment of nucleic acids. With a total of 2 patents, her work has the potential to advance methodologies in genetic analysis and treatment.

Latest Patents

Coulston's latest patents include innovative methods for treating nucleic acids. One patent focuses on the bisulphite reagent treatment of nucleic acid, which involves providing an alkali environment to a nucleic acid sample. This method allows for the reaction of the nucleic acid sample with a bisulphite reagent, resulting in a treated nucleic acid sample where methylated nucleotides remain unchanged while unmethylated nucleotides are converted to another form. The process also includes steps for removing unwanted reagents and carrying out de-sulphonation of the treated nucleic acid at elevated temperatures. Another patent addresses the treatment of methylated nucleic acids, detailing a similar process that ensures the removal of sulphonate groups from the treated nucleic acid.

Career Highlights

Coulston is currently associated with Human Genetic Signatures Pty. Ltd., where she continues to innovate in the field of genetic research. Her work is instrumental in developing methods that enhance the understanding and treatment of genetic materials.

Collaborations

Coulston collaborates with esteemed colleagues such as Douglas Spencer Millar and Cassandra Jean Vockler, contributing to a dynamic research environment that fosters innovation.

Conclusion

Neralie Ann Coulston's contributions to nucleic acid treatment exemplify the impact of innovative research in genetics. Her patents reflect a commitment to advancing methodologies that could significantly benefit the field.